Date | Name | Activity | Value |
---|---|---|---|
Dec 18, 2024 | Joseph Cappello Vp, Pharmaceutical Development | xxxxxxxxxxxxx | $14742 |
Sep 13, 2024 | Aladar Szalay >10% Owner | xxxxxxxxxxxxx | $171118 |
Sep 11, 2024 | Aladar Szalay >10% Owner | xxxxxxxxxxxxx | $196503 |
Sep 06, 2024 | Aladar Szalay >10% Owner | xxxxxxxxxxxxx | $89490 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
3,413,581 | Insider | 9.90% | 7,748,829 | |
1,157,919 | Institution | 3.35% | 2,628,476 | |
963,919 | Institution | 2.79% | 2,188,096 | |
631,307 | Institution | 1.83% | 1,433,067 | |
505,501 | Insider | 1.46% | 1,147,487 | |
213,726 | Institution | 0.62% | 485,158 | |
171,872 | Insider | 0.50% | 390,149 | |
82,452 | Insider | 0.24% | 187,166 | |
65,930 | Institution | 0.19% | 149,661 | |
63,041 | Institution | 0.18% | 143,103 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
963,919 | Institution | 2.79% | 2,188,096 | |
213,726 | Institution | 0.62% | 485,158 | |
25,224 | Institution | 0.07% | 57,258 | |
13,500 | Institution | 0.04% | 30,645 | |
7,125 | Institution | 0.02% | 16,174 | |
5,541 | Institution | 0.02% | 12,578 | |
553 | Institution | <0.01% | 1,255 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
873,800 | Institution | 2.53% | 2,813,636 | |
284,119 | Institution | 0.82% | 914,863 | |
65,930 | Institution | 0.19% | 144,387 | |
62,615 | Institution | 0.18% | 142,136 | |
2,248 | Institution | <0.01% | 45,275 |